Waste Management (WM) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
20 Apr, 2026Executive summary
Delivered record 2025 results with best-ever operating leverage and margin expansion, driven by disciplined pricing, cost efficiencies, and strategic investments in sustainability, technology, automation, and Healthcare Solutions.
Achieved double-digit growth in cash flow from operations and nearly 27% growth in free cash flow year-over-year.
Integration of Healthcare Solutions progressed, with improved customer service metrics and significant SG&A reductions.
Sustainability businesses expanded with new renewable natural gas (RNG) and Recycling facilities, driving segment EBITDA growth despite lower commodity prices.
Strategic investments in recycling, renewable energy, and healthcare solutions contributed to margin expansion and growth.
Financial highlights
Revenue for 2025 was $25.2B, up 14.2% year-over-year; Q4 revenue was $6.3B, up 7.1%.
Operating EBITDA margin expanded 40 basis points to 30.1% for 2025, overcoming a 140 basis point headwind from Healthcare Solutions acquisition and tax credit expiration.
Adjusted operating EBITDA for 2025 was $7.58B (30.1% margin), up 15.5% year-over-year.
Cash flow from operations grew over 12% to $6.04 billion; free cash flow rose nearly 27% to $2.94 billion.
Net income for 2025 was $2.71B; adjusted net income was $3.03B; diluted EPS was $6.70, adjusted diluted EPS was $7.50.
Outlook and guidance
2026 revenue projected at $26.4–$26.6B, up 5.2% at midpoint.
Operating EBITDA of $8.15–$8.25 billion expected, excluding $150 million accretion expense.
Free cash flow guidance for 2026 is $3.75–$3.85B, nearly 30% growth at midpoint; conversion above 46%.
Dividend to increase 14.5% in 2026 to $3.78 per share; new $3 billion share repurchase program authorized.
Plan to return ~$3.5B to shareholders in 2026 via dividends and share repurchases.
Latest events from Waste Management
- Revenue and EBITDA rose, free cash flow nearly doubled, and shareholder returns surged.WM
Q1 20261 May 2026 - Annual meeting covers director elections, auditor, pay, ESPP, with focus on governance and sustainability.WM
Proxy filing31 Mar 2026 - Key votes include director elections, auditor ratification, and executive compensation approval.WM
Proxy filing31 Mar 2026 - Record Q2 margin, $5.4B revenue, and major acquisitions drive strong 2024 outlook.WM
Q2 20242 Feb 2026 - Acquisition targets medical waste growth, operational synergies, and extended cash flow growth.WM
Stifel 2024 Cross Sector Insight Conference31 Jan 2026 - 2024 delivered record EBITDA and revenue; 2025 targets 15% EBITDA growth and higher dividends.WM
Q4 202428 Jan 2026 - Record Q3: 7.9% revenue growth, 30.5% margin, and Stericycle deal closing soon.WM
Q3 202427 Jan 2026 - Sustainability investments and automation drive growth, margin, and cash flow leadership.WM
Raymond James & Associates’ 46th Annual Institutional Investors Conference 20257 Jan 2026 - Sustainability investments and Stericycle integration fuel robust growth and margin expansion.WM
2025 Global Agriculture & Materials Conference23 Dec 2025